Explore our interactive case studies and see how STELFONTA® has delivered results in tumors across different locations in different breeds of dogs.
Click the images to enlarge and see each case.
- It is vital that pre- and post-treatment medications must be given to decrease the potential for severe systemic adverse reactions, including death, from mast cell degranulation.
- Formation of wounds is an intended and likely response to treatment with STELFONTA along with the associated swelling, bruising and pain; these wounds are expected to heal.
Click on the title below for open access publications.
Additional Publications and Conference Proceedings